TY - JOUR
T1 - Natural approaches in metabolic syndrome management
AU - Patti, Angelo Maria
AU - Al-Rasadi, Khalid
AU - Giglio, Rosaria Vincenza
AU - Nikolic, Dragana
AU - Mannina, Carlo
AU - Castellino, Giuseppa
AU - Chianetta, Roberta
AU - Banach, MacIej
AU - Cicero, Arrigo F.G.
AU - Lippi, Giuseppe
AU - Montalto, Giuseppe
AU - Rizzo, Manfredi
AU - Toth, Peter P.
N1 - Publisher Copyright:
Copyright © 2016 Termedia & Banach.
PY - 2018/3
Y1 - 2018/3
N2 - Metabolic syndrome (MetS) is characterized as a group of cardiometabolic risk factors that raise the risk for heart disease and other health problems, such as diabetes mellitus and stroke. Treatment strategies include pharmacologic interventions and supplementary (or "alternative") treatments. Nutraceuticals are derived from food sources (isolated nutrients, dietary supplements and herbal products) that are purported to provide health benefits, in addition to providing basic nutritional value. Nutraceuticals are claimed to prevent chronic diseases, improve health, delay the aging process, increase life expectancy, and support the structure and function of the body. The study of the beneficial effects of nutraceuticals in patients with MetS, including product standardization, duration of supplementation and definition of optimal dosing, could help better define appropriate treatment. This review focuses on widely marketed nutraceuticals (namely polyphenols, omega-3 fatty acids, macroelements and vitamins) with clinically demonstrated effects on more than one component of MetS.
AB - Metabolic syndrome (MetS) is characterized as a group of cardiometabolic risk factors that raise the risk for heart disease and other health problems, such as diabetes mellitus and stroke. Treatment strategies include pharmacologic interventions and supplementary (or "alternative") treatments. Nutraceuticals are derived from food sources (isolated nutrients, dietary supplements and herbal products) that are purported to provide health benefits, in addition to providing basic nutritional value. Nutraceuticals are claimed to prevent chronic diseases, improve health, delay the aging process, increase life expectancy, and support the structure and function of the body. The study of the beneficial effects of nutraceuticals in patients with MetS, including product standardization, duration of supplementation and definition of optimal dosing, could help better define appropriate treatment. This review focuses on widely marketed nutraceuticals (namely polyphenols, omega-3 fatty acids, macroelements and vitamins) with clinically demonstrated effects on more than one component of MetS.
KW - Cardiovascular risk
KW - Macroelements
KW - Metabolic syndrome
KW - Nutraceuticals
KW - Omega-3 fatty acids
KW - Polyphenols
KW - Vitamins
UR - http://www.scopus.com/inward/record.url?scp=85043486843&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85043486843&partnerID=8YFLogxK
U2 - 10.5114/aoms.2017.68717
DO - 10.5114/aoms.2017.68717
M3 - Review article
C2 - 29593818
AN - SCOPUS:85043486843
SN - 1734-1922
VL - 14
SP - 422
EP - 441
JO - Archives of Medical Science
JF - Archives of Medical Science
IS - 2
ER -